| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.16B | 25.10B | 31.18B | 37.31B | 30.40B | 22.92B |
| Gross Profit | 8.99B | 7.82B | 11.09B | 14.72B | 10.23B | 6.41B |
| EBITDA | 6.32B | 6.05B | 8.12B | 11.59B | 7.60B | 4.41B |
| Net Income | 4.15B | -74.00M | 5.75B | 7.30B | 5.40B | 3.04B |
Balance Sheet | ||||||
| Total Assets | 82.64B | 87.02B | 81.93B | 88.57B | 73.00B | 63.01B |
| Cash, Cash Equivalents and Short-Term Investments | 20.76B | 17.53B | 17.42B | 22.34B | 19.37B | 22.44B |
| Total Debt | 39.00M | 33.00M | 9.00M | 1.00M | 7.00M | 17.00M |
| Total Liabilities | 8.25B | 9.39B | 8.13B | 15.68B | 10.58B | 6.95B |
| Stockholders Equity | 74.37B | 77.61B | 73.79B | 72.88B | 62.40B | 56.05B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.20B | -2.00B | 4.55B | 69.00M | 6.81B |
| Operating Cash Flow | 0.00 | 7.77B | 4.55B | 7.79B | 2.34B | 7.62B |
| Investing Cash Flow | 0.00 | -7.14B | -5.40B | -16.03B | -4.35B | -954.00M |
| Financing Cash Flow | 0.00 | -2.01B | -2.99B | -1.39B | -1.03B | -826.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥53.95B | 25.62 | 9.07% | 4.46% | 3.09% | 22.56% | |
71 Outperform | ¥32.17B | 8.51 | ― | 3.84% | 3.45% | 14.22% | |
69 Neutral | ¥51.20B | -711.15 | ― | 4.32% | -19.49% | -101.29% | |
67 Neutral | ¥27.57B | 39.81 | ― | 3.21% | 2.43% | 17.77% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥43.39B | -44.17 | ― | 3.24% | 2.94% | -136.46% | |
56 Neutral | ¥341.45B | 32.98 | 6.95% | 3.06% | -6.88% | ― |